European Journal of Heart Failure

Papers
(The H4-Index of European Journal of Heart Failure is 54. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Adrenomedullin as a Marker of Hypoxia, Not Hypoperfusion. Letter Regarding the Article ‘Biologically Active Adrenomedullin as a Marker for Residual Congestion and Early Rehospitalization in Patients H420
Issue Information240
Machine learning to reveal hidden HFpEF: promise, pitfalls, and next steps190
170
Issue Information154
Tafamidis in Patients with Severe Heart Failure due to Transthyretin Amyloidosis Cardiomyopathy: Improved Long-Term Survival151
Rationale and Design of the ESC Heart Failure III Registry – Implementation and Discovery149
Effect of Dapagliflozin on Health Status and Quality of Life Across the Spectrum of Ejection Fraction: Participant-Level Pooled Analysis from the DAPA-HF and DELIVER Trials124
Association Between Liver Fibrosis, Plasma Volume Status, and Cardiovascular Mortality: The Hiroshima Study on Glucose Metabolism and Cardiovascular Diseases123
Clonal hematopoiesis is linked to increased risks of all-cause mortality, cardiovascular death, and bleeding complications in patients with atrial fibrillation102
Effect of Sacubitril/Valsartan in Heart Failure with Preserved Ejection Fraction Across the Age Spectrum in PARAGON-HF100
Time-Varying Analyses of Survival and Outcomes in Patients with HeartMate 3 Left Ventricular Assist Devices97
Subclinical atrial fibrillation and the risk of heart failure: insights from ARTESiA93
Striving for the ‘Perfect’ Definition of Iron Deficiency in Heart Failure88
Letter regarding the article ‘Clinical profiles and prognostic impact of residual intravascular and tissue congestion in acute heart failure’88
Similarities and Distinctions Between Acetazolamide and Sodium–Glucose Cotransporter 2 Inhibitors in Patients with Acute Heart Failure: Key Insights Into ADVOR and EMPULSE86
Identifying Reliable Biomarkers for Pulmonary Congestion: Toward a Close Yet Sustainable Heart Failure Follow-Up86
Reply to the letter regarding the article ‘Are mechanical circulatory supports the forgotten aspect in the implementation of therapies for heart failure?’82
Applying the ‘Touch-and-Go’ Concept to Mineralocorticoid Receptor Antagonists: A Paradigm Shift in Routine Heart Failure Management80
Issue Information78
Dissecting the Heart Failure Phenotype Through Phenomics78
Abstract76
Reply to ‘Morphine use in acute cardiogenic pulmonary oedema: is MIMO trial enough to change practice?’73
Expanding the Horizon of Medication Adherence Strategies in Acutely Decompensated Heart Failure. Letter Regarding the Article ‘Medication Adherence in Patients with Acutely Decompensated Heart Failure73
Letter Regarding the Article ‘Employment of Artificial Intelligence for an Unbiased Evaluation Regarding the Recovery of Right Ventricular Function After Mitral Valve Transcatheter Edge-To-Edge Repair73
Response to Letter EURJHF-25-145571
Are Left Ventricular Ejection Fraction Phenotypes Meaningful in Acute Heart Failure?70
Cardiovascular Magnetic Resonance-Estimated Pulmonary Capillary Wedge Pressure, Congestion Markers, and Effect of Empagliflozin in Patients with Heart Failure with Reduced Ejection Fraction and Dysgly69
Abstract68
Characteristics and Outcomes of Patients with a History of Cancer Recruited to Heart Failure Trials68
Correction to: Association of patient-centred remote monitoring with clinical outcomes in patients with prior hospitalization: the TELESAT PRIOR-HF study67
Single-cell transcriptomics uncovers immune remodeling in heart failure complicated by myocarditis67
Heterogeneity of ejection fraction recovery in acute heart failure with reduced ejection fraction: a phenotype-based analysis from a nationwide registry66
Heterogeneity of recovery in HFrEF: biochemical and structural recovery phenotypes and prognosis65
Impact of myocardial fibrotic changes assessed by magnetic resonance imaging on early postoperative outcomes after aortic valve replacement64
Tirzepatide use in patients with heart failure with preserved ejection fraction and obesity in clinical practice63
Early dapagliflozin therapy after STEMI in patients with preserved ejection fraction: a prospective cohort study63
Factors associated with one-year maintenance of sinus rhythm after successful electrical cardioversion of persistent atrial arrhythmias in patients with cardiac implantable electronic devices62
Invasive haemodynamics and advanced echocardiography to define the diagnostic and prognostic value of left atrial function in advanced heart failure62
Prevalence and characterization of normotensive shock in intermediate-high risk acute pulmonary embolism patients62
Early coronary angiography and survival in older adults with nstemi: a frailty-adjusted analysis60
Role of balance and physical fitness in assessing the effectiveness of cardiac rehabilitation on functional recovery60
Hidden malnutrition and sarcopenic obesity in older heart failure outpatients59
Evolution of congestion during post-discharge follow-up in a heart failure unit59
Aortic valve stenosis is unrelated to the severity of transthyretin amyloid cardiomyopathy and is instead linked to aging58
Reassessing treatment strategies for obstructive prosthetic valve thrombosis: fibrinolysis or urgent surgery?58
Genetic variants identify patients with myocarditis at higher risk for ICD implantation57
Impact of sodium-glucose cotransporter-2 inhibitors on clinical outcomes in patients with valvular heart diseases and type 2 diabetes57
A novel right ventricular morphofunctional index integrating geometry and RV pulmonary arterial coupling for risk stratification in heart failure56
Safety and efficacy of targeted pharmacotherapy in elderly patients with pulmonary arterial hypertension56
Genotype-driven differences in the phenotype and prognosis of patients with hypertrophic cardiomyopathy55
Validating prediction models for hypertrophic cardiomyopathy genotype positivity55
Admission NT-proBNP and in-hospital mortality in acute heart failure: a real-world emergency cohort study54
Relationship between resting hemodynamic parameters and exercise capacity in patients with advanced heart failure: a single-centre experience54
Heart failure with preserved ejection fraction in the elderly: clinical, imaging, and biomarker profiles according to global longitudinal strain by cardiac magnetic resonance54
0.17866992950439